Oral Laquinimod for MS!

I’d like to mention briefly Laquinimod here..

Laquinimod is an investigational, novel, once-daily oral immunomodulator. It was developed as a disease-modifying treatment for RRMS and is nearing end of trial phase. It is expected to be completed by Q3 next year!

Besides being tested for the treatment of RRMS, it is in development for Crohn’s disease and Lupus, and is being researched for other autoimmune diseases as well!

On September 21st, Medical News Today reported that, thus far, Laquinimod has demonstrated a sustained positive benefit-risk profile through the trials undertaken. Doctors are looking forward to confirming these in the final study phases next year.

We have one more oral drug for MS to look forward to!! : )

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: